# Uterine Transposition: Feasibility Study

> **NCT03040921** · NA · COMPLETED · sponsor: **Hospital Erasto Gaertner** · enrollment: 9 (actual)

## Conditions studied

- Postoperative Complications
- Intraoperative Complications
- Tissue Damage
- Ovarian Failure
- Uterus Disorder

## Interventions

- **PROCEDURE:** Uterine transposition.

## Key facts

- **NCT ID:** NCT03040921
- **Lead sponsor:** Hospital Erasto Gaertner
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-06-01
- **Primary completion:** 2019-06-01
- **Final completion:** 2021-04-01
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2022-01-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03040921

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03040921, "Uterine Transposition: Feasibility Study". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03040921. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*